Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 50005668
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004058(N-(butylsulfonyl)-O-(4-piperidin-4-ylbutyl)-L-tyro...)
Affinity DataIC50: 9nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039593((S)-3-[4-(4-Piperidin-4-yl-butoxy)-phenyl]-2-(thio...)
Affinity DataIC50: 15nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039590((S)-2-Benzenesulfonylamino-3-[4-(4-piperidin-4-yl-...)
Affinity DataIC50: 18nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004071(CHEMBL420966 | (S)-2-Phenylmethanesulfonylamino-3-...)
Affinity DataIC50: 18nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039592((S)-3-[4-(4-Piperidin-4-yl-butoxy)-phenyl]-2-(prop...)
Affinity DataIC50: 23nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039580((S)-2-(2-Phenyl-ethanesulfonylamino)-3-[4-(4-piper...)
Affinity DataIC50: 29nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004061((S)-2-Hexanoylamino-3-[4-(4-piperidin-4-yl-butoxy)...)
Affinity DataIC50: 35nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039576((S)-2-((E)-2-Phenyl-ethenesulfonylamino)-3-[4-(4-p...)
Affinity DataIC50: 43nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039572((S)-2-Pentanoylamino-3-[4-(4-piperidin-4-yl-butoxy...)
Affinity DataIC50: 47nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039591((S)-2-Methanesulfonylamino-3-[4-(4-piperidin-4-yl-...)
Affinity DataIC50: 63nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039595((S)-2-(3-Phenyl-propionylamino)-3-[4-(4-piperidin-...)
Affinity DataIC50: 100nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039570((S)-3-[4-(4-Piperidin-4-yl-butoxy)-phenyl]-2-propi...)
Affinity DataIC50: 105nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039569((S)-3-(Butane-1-sulfonylamino)-4-[4-(4-piperidin-4...)
Affinity DataIC50: 140nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039586((S)-2-Benzyloxycarbonylamino-3-[4-((E)-4-piperidin...)
Affinity DataIC50: 240nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004060(CHEMBL85152 | 2-Benzyloxycarbonylamino-3-[4-(4-pip...)
Affinity DataIC50: 260nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039597((S)-2-Acetylamino-3-[4-(4-piperidin-4-yl-butoxy)-p...)
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039588((S)-2-Benzyloxycarbonylamino-3-[4-(4-piperazin-1-y...)
Affinity DataIC50: 500nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039568((S)-3-(Butane-1-sulfonylamino)-4-[4-(3-piperidin-4...)
Affinity DataIC50: 600nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039601((4S,7R,13R,16S)-16-Acetylamino-7-carboxymethyl-13-...)
Affinity DataIC50: 680nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004065(CHEMBL86115 | (S)-3-[4-(6-Amino-hexyloxy)-phenyl]-...)
Affinity DataIC50: 780nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039584((R)-2-(Butane-1-sulfonylamino)-3-[4-(4-piperidin-4...)
Affinity DataIC50: 800nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039577((S)-3-Benzyloxycarbonylamino-4-[4-(3-piperidin-4-y...)
Affinity DataIC50: 880nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039571((S)-2-Benzyloxycarbonylamino-3-[4-(5-piperazin-1-y...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039581((S)-2-Hexanoylamino-3-[4-(5-piperidin-4-yl-pentyl)...)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039573(2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butyl...)
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004066(CHEMBL85261 | 3-[4-(6-Amino-hexyloxy)-phenyl]-2-ph...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004062(CHEMBL85544 | (S)-3-[4-(7-Amino-heptyloxy)-phenyl]...)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004064(CHEMBL83079 | 3-[4-(6-Amino-hexyloxy)-phenyl]-2-he...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039585((S)-2-Benzyloxycarbonylamino-3-{4-[3-(4-methyl-pip...)
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039579((S)-3-[4-(6-Amino-hexyloxy)-phenyl]-2-butyrylamino...)
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039596((S)-2-Benzyloxycarbonylamino-3-[4-(3-piperidin-4-y...)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004067(CHEMBL86193 | 3-[4-(6-Amino-hexyloxy)-phenyl]-2-(3...)
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039594((S)-3-[4-(6-Amino-hexyloxy)-phenyl]-2-benzoylamino...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039600((S)-3-[4-(6-Amino-hexyloxy)-phenyl]-2-methanesulfo...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039599((S)-3-[4-(6-Amino-hexyloxy)-phenyl]-2-phenylacetyl...)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039573(2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butyl...)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to vitronectinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039574((S)-2-Acetylamino-3-[4-(6-amino-hexyloxy)-phenyl]-...)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039587((S)-2-Benzyloxycarbonylamino-3-{4-[3-(3-dimethylam...)
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039582((S)-2-(Benzyloxycarbonyl-methyl-amino)-3-[4-(4-pip...)
Affinity DataIC50: 2.20E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039598((S)-2-Benzyloxycarbonylamino-3-[4-(3-pyrrolidin-1-...)
Affinity DataIC50: 2.30E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039583(3-[4-(4-Piperidin-4-yl-butoxy)-phenyl]-propionic a...)
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004070((S)-3-[4-(6-Amino-hexyloxy)-phenyl]-2-benzyloxycar...)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039573(2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butyl...)
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to fibronectinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004059((S)-2-Benzyloxycarbonylamino-3-[4-(3-tert-butylami...)
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50039573(2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butyl...)
Affinity DataIC50: 3.40E+4nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to fibrinogenMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004069((S)-2-Amino-3-[4-(6-amino-hexyloxy)-phenyl]-propio...)
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004072(CHEMBL83247 | 2-Benzyloxycarbonylamino-3-[4-(3-ter...)
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004063(CHEMBL86080 | 3-[4-(5-Amino-pentyloxy)-phenyl]-2-b...)
Affinity DataIC50: 3.60E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004056(3-[4-(8-Amino-octyloxy)-phenyl]-2-benzyloxycarbony...)
Affinity DataIC50: 3.80E+4nMAssay Description:Inhibition of platelet aggregation as the concentration necessary to inhibit the change in light. More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50004060(CHEMBL85152 | 2-Benzyloxycarbonylamino-3-[4-(4-pip...)
Affinity DataIC50: 5.60E+4nMAssay Description:Inhibition of human umbilical vein endothelial cell adhesion to vitronectinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: